Skip to main content
. Author manuscript; available in PMC: 2014 Mar 24.
Published in final edited form as: Clin Genitourin Cancer. 2012 Jun 12;10(4):232–238. doi: 10.1016/j.clgc.2012.05.001

Table 3.

Treatment Response by PSA Levels

Treatment Response Ridaforolimus (N = 38) Number of Patients, n (%)
PSA Response 0 (0)
PSA Stable Disease 8 (21.1)
PSA Progression 23 (60.5)
Unable to Evaluate 4 (10.5)
Not Assessed 3 (7.9)

Abbreviation: PSA = prostate-specific antigen.